期刊文献+

参加IAEA关于正电子放射性药品会议后的思考 被引量:1

Introduction of IAEA Meeting In Bangkok and Thinking on Control of Pet Radiopharmaceuticals
暂未订购
导出
摘要 目的为加强我国正电子放射性药品的监督管理提供参考。方法简要介绍了国际原子能机构于2008年3月在泰国曼谷举行的"建立回旋加速器放射性药物生产设施和实施GMP的主题会议"有关情况。结果与结论通过参加这次国际会议,认识到我国医疗机构制备正电子放射性药品管理上的不足,并提出了相关建议以加强正电子放射性药品的管理。 Objective It was reference to strengthen the supervision and management of PET radiopharmaceuticals. Methods The article briefly introduced the Thematic Meeting on Establishment of Cyclotron Radiopharmaceutical Production Facility and Implementation of cGMP held by IAEA in Bangkok, Thailand, March, 2008. Results and Conclusions Through attending the meeting, we realized the deficiency for the control of PET radiopharmaceuticals produced by medical institutions in China, and gave some suggestions on how to improve the management of PET radiopharmaceuticals.
出处 《中国药事》 CAS 2009年第7期715-717,共3页 Chinese Pharmaceutical Affairs
关键词 IAEA会议 正电子放射性药品 管理 IAEA meeting PET radiopharmaceuticals management
  • 相关文献

参考文献3

  • 1张锦荣,罗志福.中国放射性同位素技术与应用进展[J].中国工程科学,2008,10(1):61-69. 被引量:27
  • 2国家药品监督管理局,卫生部.关于印发《医疗机构制备正电子类放射性药品管理暂行规定》的通知[Z].国药管安[2000]496号,2000.
  • 3国家食品药品监督管理局,卫生部.关于印发《医疗机构制备正电子类放射性药品管理规定》的通知[Z].国食药监安[2006]4号,2006.

共引文献26

同被引文献22

  • 1张锦明,田嘉禾.国内正电子放射性药物发展现状简介[J].同位素,2006,19(4):240-245. 被引量:24
  • 2金征宇.医学影像学[M].2版.北京:人民卫生出版社,2010:20.
  • 3Ido T, Wan CN, Fowler JS, et al. Fluorination with F2: a convenient synthesis of 2-deoxy-2-fluoro-D-glucose[J]. J Org Chem, 1977,42(13) :2 341.
  • 4Shankar V, Lilja S, Brigitte V. A broad overview of posi- tron emission tomography radiopharmaceuticals and clini- cal applications: what is new?[J]. Semin Nucl Med, 2011, 41(4):246.
  • 5Intemational Atomic Energy Agency. Nuclear technology review 2010[R/OL]. (2010-08-10) [2012-09-12].http:// www.iaea.org/About/Policy/GC/GC54/GC54InfDocuments/ English/gc54inf-3_en.pdf.
  • 6卫生部.2011-2015年全国正电子发射型断层扫描仪配置规划[EB/OL].(2011-11-02)[2012-05-30].http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohghcws/s3585/201111/53257.htm.
  • 7Henry F, van Brocklin. Radiopharmaceuticals for drug de- velopment: United States regulatory perspective[J]. Cur- rent Radiopharmaceuticals, 2008,1 ( 1 ) : 2.
  • 8FDA. Current good manufacturing practice for positron emission tomography drugs[J]. Fed Regist, 2009, 74 (236) :65 409.
  • 9Kotz D. Congress passes FDA reform act: nuclear medi- cine community stands to gain[J]. J Nucl Med, 1998, 39 ( 1 ) : 15N- 16N, 18N.
  • 10中华人民共和国国务院.放射性药品管理办法[S/OL].(1989-01-13) [2012-09-12].http.//www.sda.gov.cn/WS 01/CL0056/10771.html.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部